Sofosbuvir/velpatasvir regimen promises an effective pan-genotypic hepatitis C virus cure

Sofosbuvir/velpatasvir regimen promises an effective pan-genotypic hepatitis C virus cure

Fazia Mir, Alp S Kahveci, Jamal A Ibdah, Veysel Tahan Division of Gastroenterology and Hepatology, University of Missouri, Columbia, MO, USA Abstract: Hepatitis C virus (HCV) is a global pandemic, with nearly 200 million infected patients worldwide. HCV is the most common blood-borne infection in...

Full description

Bibliographic Details
Main Authors: Mir F, Kahveci AS, Ibdah JA, Tahan V
Format: Article
Language:English
Published: Dove Medical Press 2017-02-01
Series:Drug Design, Development and Therapy
Subjects:
Sofosbuvir
velpatasvir
hepatitis C
treatment
pan-genotypic
genotype
Online Access:https://www.dovepress.com/sofosbuvirvelpatasvir-regimen-promises-an-effective-pan-genotypic-hepa-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/sofosbuvirvelpatasvir-regimen-promises-an-effective-pan-genotypic-hepa-peer-reviewed-article-DDDT

Similar Items